Indication
Mixed bipolar I disorder
Mixed bipolar I disorder refers to a presentation of bipolar I disorder—a severe, recurrent neuropsychiatric condition of the central nervous system—characterized by episodes that blend opposing affective poles. Read more about Mixed bipolar I disorder
117 drugs 71 manufacturers
Drugs that treat it
Common Mixed bipolar I disorder therapies.
CARBATROL (carbamazepine)
RISPERIDONE
RISPERDAL (risperidone)
DEPAKOTE ER (divalproex sodium)
SAPHRIS (asenapine maleate)
FANAPT (iloperidone)
FANAPT (iloperidone)
CARBAMAZEPINE ER (carbamazepine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMixed bipolar I disorder refers to a presentation of bipolar I disorder—a severe, recurrent neuropsychiatric condition of the central nervous system—characterized by episodes that blend opposing affective poles.
In regulatory indications and clinical practice, this reflects mixed episodes or manic/depressive episodes meeting criteria for the "with mixed features" specifier, where symptoms of mania (such as psychomotor agitation, racing thoughts, and elevated energy) co-occur alongside prominent depressive features (such as dysphoria, hopelessness, and pervasive fatigue).
Pathophysiologically linked to complex disruptions in circadian regulation, frontolimbic circuits, and monoaminergic neurotransmission, this clinical subtype is associated with heightened illness severity, diagnostic instability, and an elevated risk of functional impairment and suicidality.
- nih.gov
Mixed bipolar I disorder refers to a presentation of bipolar I disorder—a severe, recurrent neuropsychiatric condition of the central nervous system—characterized by episodes that blend opposing affective poles Pathophysiologically linked to complex disruptions in circadian regulation, frontolimbic circuits, and monoaminergic neurotransmission, this clinical subtype is associated with heightened illness severity, diagnostic instability, and an elevated risk of functional impairment and suicidali...
- nih.gov
Mixed bipolar I disorder refers to a presentation of bipolar I disorder—a severe, recurrent neuropsychiatric condition of the central nervous system—characterized by episodes that blend opposing affective poles
- nih.gov
In regulatory indications and clinical practice, this reflects mixed episodes or manic/depressive episodes meeting criteria for the "with mixed features" specifier, where symptoms of mania (such as psychomotor agitation, racing thoughts, and elevated energy) co-occur alongside prominent depressive features (such as dysphoria, hopelessness, and pervasive fatigue)
- advancedpsychiatryassociates.com
In regulatory indications and clinical practice, this reflects mixed episodes or manic/depressive episodes meeting criteria for the "with mixed features" specifier, where symptoms of mania (such as psychomotor agitation, racing thoughts, and elevated energy) co-occur alongside prominent depressive features (such as dysphoria, hopelessness, and pervasive fatigue)
- nih.gov
In regulatory indications and clinical practice, this reflects mixed episodes or manic/depressive episodes meeting criteria for the "with mixed features" specifier, where symptoms of mania (such as psychomotor agitation, racing thoughts, and elevated energy) co-occur alongside prominent depressive features (such as dysphoria, hopelessness, and pervasive fatigue) Pathophysiologically linked to complex disruptions in circadian regulation, frontolimbic circuits, and monoaminergic neurotransmission,...
Personalize your experience
Follow Mixed bipolar I disorder and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.